Table 3 Results of the intention-to-treat analysis for general and behavioural development

From: Is there an effect of intranasal insulin on development and behaviour in Phelan-McDermid syndrome? A randomized, double-blind, placebo-controlled trial

 

Control rate

Insulin effect

Total rate

Control rate

Insulin effect

 

All ages

All ages

All ages

Age >36 months

Age >36 months

 

C

P-value

C

P-value

C

95% CI

C

P-value

C

P-value

B: cognition

0.40

0.30

0.57

0.11

0.97

(0.36; 1.58)

0.19

0.64

0.75

0.046

B: receptive language

1.02

0.02

0.63

0.13

1.64

(1.04; 2.25)

0.87

0.05

0.60

0.14

B: expressive language

1.35

0.002

0.05

0.92

1.39

(0.85; 1.94)

1.09

0.02

0.29

0.54

B: fine motor function

0.47

0.18

0.41

0.26

0.87

(0.38; 1.37)

0.30

0.44

0.56

0.15

B: gross motor functiona

1.82

0.01

−0.07

0.92

1.75

(1.12; 2.38)

1.82

0.004

−0.01

0.99

V: communication skillsb

0.11

0.80

0.57

0.19

0.68

(0.004; 1.35)

0.14

0.76

0.56

0.32

V: social skills

−0.12

0.88

1.41

0.06

1.29

(0.11; 2.47)

−0.45

0.57

1.54

0.042

V: daily skills

0.14

0.78

0.84

0.14

0.97

(0.33; 1.61)

0.04

0.94

1.10

0.07

V: motor skills

0.30

0.64

1.21

0.09

1.51

(0.62; 2.40)

0.07

0.91

1.28

0.10

E: social developmenta

2.39

0.13

0.56

0.76

2.96

(1.08; 4.83)

2.31

0.18

0.93

0.64

E: emotional developmenta

0.50

0.61

0.07

0.95

0.57

(−0.59; 1.74)

0.47

0.66

0.05

0.97

  1. Abbreviations: B, Bayley-III-NL; V, Vineland Screener 0-6 and E=ESSEON.
  2. aThe random coefficients model was reduced to a random intercept model since the variability in the slope was estimated to be zero for ‘all ages’ and ‘age >36 months’ and
  3. bfor ‘age >36 months’ only. All ages n=25, Age >36 months n=21. The coefficient (C) is an estimate of the change in DAE in months per 6 months for the pre-treatment period (control rate) and treatment period (insulin effect). Observed insulin effects that show a clinical increase in DAE are underlined. The P-value (P) is calculated for the difference between the DAE at the beginning and the end of these respective periods. P<0.05 is considered statistically significant. Significant P-values of insulin effects are bold. The confidence interval (CI) represents the distribution of the individual coefficients.